Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04861129
Other study ID # RCT_BT_2021
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date April 19, 2021
Est. completion date June 30, 2022

Study information

Verified date April 2021
Source The Hong Kong Polytechnic University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is emerging evidence that Bowen Therapy may improve musculoskeletal pain. While it can be an effective treatment strategy to enhance pain modulation; studies on the clinical effect are scarce. The aim of this study is to examine the effectiveness of Bowen therapy for people with chronic LBP on measures of pain, function, pain-related self-efficacy, and health related quality of life. Parallel-group randomized controlled trial (RCT) study will be employed. Pain Catastrophizing Scale (PCS) will be adopted as a screening test upon the randomization. A cutoff of more than 30 points will be used to represents clinically relevant level of catastrophizing. 46 participants with informed consent who meet the eligibility criteria of study are recruited and randomly assigned to one of two groups i.e. Bowen Therapy group and Sham Bowen Conventional Therapy group. Permuted block randomization is applied to control the key confounding variable of catastrophizing which is significantly associated with pain and disability in chronic LBP. Sequentially numbered, opaque, sealed envelopes (SNOSE) is used to ensure the allocation sequence before the group allocation. Double blinding of participants and outcome assessor will be adopted. Measurements are collected at the baseline (Week 0), post-intervention (Week 6) and at a 4-week follow-up (Week 10). The primary outcomes are pain as measured by Percentage of Pain Intensity Difference (PID) and pain relief scale (PRS). The secondary outcomes are measuring the physical functioning, self-efficacy in pain and HRQoL using Owestry Disability Index (ODI), Pain Self-efficacy Questionnaire (PSEQ) and SF-12 (HK) respectively. Intervention is provided weekly for 6 sessions lasting 30-40 minutes per treatment session. The experimental group will receive Bowen therapy according to ISBT Bowen Therapy®. The control group will receive a usual OT therapy with the same number of treatment session, treatment time, including back care advice and functional rehab training.


Description:

Low back pain (LBP) is one of the most common condition resulting in socioeconomic burden on health care systems. LBP is defined as pain, muscle tension, or stiffness in the area between the lower posterior margin of the rib cage and the horizontal gluteal fold with or without leg pain. Acute LBP is defined as pain that lasts less than 6 weeks, sub-acute LBP lasts for 6 to 12 weeks, and chronic LBP lasts for longer than 12 weeks. Prevalence study in Hong Kong showed that an estimated 57.1% and 42.1% of the population reported of LBP at least once in their life time and at least once within the past year respectively. In the past decades, several multidisciplinary clinical guidelines were developed in Canada, UK and US for the management of LBP which aimed to promote consistent best practice in patient care. All the guidelines recommended exercise therapy as one the strategy in terms of non-pharmacological, non-invasive management. The National Institute for Health and Care Excellence (NICE) guideline suggested that group exercise programme (biomechanical, aerobic, mind-body or a combination of approaches) should be provided for people with single episode or flare-up of LBP with or without sciatica. Whereas manual therapy could be offered only alongside exercise. Both US and Canadian guidelines advocated similar recommendations. However, none of the guidelines were able to specify which forms of manual therapy is superior for the management of chronic LBP. Bowen therapy is a complementary and alternative medicine involving light touch over the fascial, specific muscles, tendons and connective tissues to improve flow of blood, lymph and energy. It is one of the fascial techniques which aims to release the muscle tension, improve pain and restore function. Bowen therapy was named after Tom Bowen (1916-1982) and also known as Bowen Technique, Bowenwork and Bowtech which are interchangeable in the literature. It promotes connective tissues to slide over each other and improve the afferents responses in response to dysfunction. While Bowen therapy can be an effective treatment strategy to enhance pain modulation; studies on the mechanism of action of Bowen therapy and its clinical effect are scarce. In most instances, the basic Bowen moves are applied using the fingers and thumbs. It involves taking a slack over skin, applying a gentle non-invasive pressure over muscles, tendon and fascia. Other techniques including fast release, gentle stretching, repetitive squeezing will be used according to the therapist's assessment. Bowen therapy could facilitate tissue hydration and recoiling properties of fascia. It was suggested that Bowen moves in slow release can activate various sensory receptors (e.g. Merkel's Discs, Meissner's corpuscles and Free Nerve Endings) and mechanoreceptors (e.g. Golgi tendon organs, Ruffini endings and Interstitial receptors). For the Bowen moves in fast release, Pacini corpuscles can be activated. The activation of various Golgi tendon organs can lower the sympathetic nervous system (SNS) activity. Furthermore, interstitial receptors stimulated by Bowen moves can also lower SNS and increase vagal tone to achieve the deep relaxing effect and reduction of nerve pressure. It is suggested to adopt different treatment technique of approach to target the dysfunction arising from various types of fascia. The deep fasciae and the epymisium are related to adjustment in coordination, proprioception, balance, myofascial pain, and muscle cramps. According to different anatomical locations and fascial tissue, enough pressure with manual deep friction is required in order to reach the deep fasciae and epymisium. It can explain why some Bowen moves (e.g. Hamstring sequence on biceps femoris) using elbow instead of fingers to exert enough pressure on the soft tissue. Yet in most instances, light massage, which can be achieved in most of the basic Bowen moves, are adequate to address the pain caused by superficial fascia. The Bowen moves also follows a planned sequence of stimulation based on the evidence on myofascial continuity. In Bowen therapy session, two-minute pauses are applied between a set of Bowen moves, that muscle spindles are activated upon the stretch on the muscle fibers. It can be explained by the general pain sensitization of nerve pathways commonly found in people with chronic pain, and so two-minute waiting time allows the body to make appropriate adjustments to re-align and balance, through the mediation at the spinal cord and central nervous system. Although clinical practice implies that Bowen therapy is a useful technique, particularly in relation to improved pain, joint mobility and functional status; there is still little published research in the literature about the clinical effect of Bowen therapy. Moreover, majority of the studies reviewed lack of control group design and methodological issues, including small sample size, poor sampling method, inadequate information of study sample, and lack of standardized measurement tools. More vigorous and stringent research design is warranted for the future research study.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 46
Est. completion date June 30, 2022
Est. primary completion date September 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - ages between 18 and 65 years - a diagnosis of low back pain with onset > 12 weeks based on the evaluation by physician - average pain intensity score of = 3 on NPRS. Exclusion Criteria: - they have acute disc prolapse or protusion with neurological sign and symptoms in the past 3-months; - bacterial spondylitis; - Rheumatoid arthritis; - ankylosing spondylitis; - back pain secondary to bone malignancy - spinal fracture; - osteoporotic collapse; - cauda equina compression - prior spinal surgery; - psychiatric disorder (e.g. psychosis / delusion); - current pregnancy - previous experience with Bowen therapy.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Bowen therapy
Intervention is provided weekly for 6 sessions lasting 30-40 mins per treatment session
Sham Bowen therapy
Sham Intervention is provided weekly for 6 sessions lasting 30-40 mins per treatment session

Locations

Country Name City State
Hong Kong United Christian Hospital Kwun Tong

Sponsors (2)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University United Christian Hospital

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Percentage of Pain Intensity 11-point scale by reporting a number from 0 - 10, with "0' representing "no pain" and "10" representing the "most intense pain imaginable". Therefore, the change in pain intensity is expressed as the percentage of pain intensity difference (%PID), which converts the raw score change to a proportional measure i.e. pain intensity difference between the assessments / Pain NRS at baseline assessment. (Score: 0 - 100%) Week 6 (compared to Week 0)
Primary Change of Percentage of Pain Intensity 11-point scale by reporting a number from 0 - 10, with "0' representing "no pain" and "10" representing the "most intense pain imaginable". Therefore, the change in pain intensity is expressed as the percentage of pain intensity difference (%PID), which converts the raw score change to a proportional measure i.e. pain intensity difference between the assessments / Pain NRS at baseline assessment. (Score: 0 - 100%) Week 10 (compared to Week 0)
Primary Pain relief scale 11-point scale with "0" representing "no relief of pain" and "10" representing "completely relieved" to measure the magnitude of change in pain intensity after the treatment. (Score: 0 - 100%) Week 0
Primary Pain relief scale 11-point scale with "0" representing "no relief of pain" and "10" representing "completely relieved" to measure the magnitude of change in pain intensity after the treatment. (Score: 0 - 100%) Week 6
Primary Pain relief scale 11-point scale with "0" representing "no relief of pain" and "10" representing "completely relieved" to measure the magnitude of change in pain intensity after the treatment. (Score: 0 - 100%) Week 10
Secondary Owestry Disability Index Each section has scored from 0 to 5, with 0 representing "no disability" and 5 representing "greatest disability", yielding a total possible score of 50. Finally the score multiplied by two to obtain the index (Score: 0 to 100). Week 0
Secondary Owestry Disability Index Each section has scored from 0 to 5, with 0 representing "no disability" and 5 representing "greatest disability", yielding a total possible score of 50. Finally the score multiplied by two to obtain the index (Score: 0 to 100). Week 6
Secondary Owestry Disability Index Each section has scored from 0 to 5, with 0 representing "no disability" and 5 representing "greatest disability", yielding a total possible score of 50. Finally the score multiplied by two to obtain the index (Score: 0 to 100). Week 10
Secondary Chinese version of Pain Self-efficacy Questionnaire It comprised of 10 items which was rated on a 7-point scale ranging from 0 equals "not at all confident" to 6 equals "completely confident". The total score is calculated by summing up all the items, yielding a maximum possible score of 60. The higher PSEQ score indicated that patients with higher self-efficacy beliefs on performing activities. (Scoring 0 - 60) Week 0
Secondary Chinese version of Pain Self-efficacy Questionnaire It comprised of 10 items which was rated on a 7-point scale ranging from 0 equals "not at all confident" to 6 equals "completely confident". The total score is calculated by summing up all the items, yielding a maximum possible score of 60. The higher PSEQ score indicated that patients with higher self-efficacy beliefs on performing activities. (Scoring 0 - 60) Week 6
Secondary Chinese version of Pain Self-efficacy Questionnaire It comprised of 10 items which was rated on a 7-point scale ranging from 0 equals "not at all confident" to 6 equals "completely confident". The total score is calculated by summing up all the items, yielding a maximum possible score of 60. The higher PSEQ score indicated that patients with higher self-efficacy beliefs on performing activities. (Scoring 0 - 60) Week 10
Secondary 12-item Chinese (Hong Kong) Short Form Health Survey (version 2) Higher component summary scores indicate better health and better HRQoL. Range of 0-100 (zero indicating the poorest level of health measured and 100 indicating the highest) Week 0
Secondary 12-item Chinese (Hong Kong) Short Form Health Survey (version 2) Higher component summary scores indicate better health and better HRQoL. Range of 0-100 (zero indicating the poorest level of health measured and 100 indicating the highest) Week 6
Secondary 12-item Chinese (Hong Kong) Short Form Health Survey (version 2) Higher component summary scores indicate better health and better HRQoL. Range of 0-100 (zero indicating the poorest level of health measured and 100 indicating the highest) Week 10
See also
  Status Clinical Trial Phase
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2
Completed NCT03350256 - BurstDR™ micrOdosing stimuLation in De-novo Patients N/A
Recruiting NCT05616702 - Effectiveness of Pressure Biofeedback Therapy and Progressive Muscle Relaxation Technique in Improving Pain and Disability Among Patients With Non-Specific Low Back Pain N/A
Completed NCT04919278 - Ciropractic Care and Pregnant Women N/A
Completed NCT03704311 - Evaluation of Mitochondrial Function in Myofascial Trigger Points Cohort Pilot Study Using High-resolution Respirometry N/A
Recruiting NCT05058287 - Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression Phase 3
Recruiting NCT04640896 - Trigger Point Injections in Anterior Cervical Surgery Phase 4
Terminated NCT03421951 - Change in Pain and Quality of Life Following SCS for Chronic Pain
Completed NCT03317275 - Diagnostic Value of 18F-Fluoride-PET/MRI in the Management of Suspected Facet Joint Arthropathy N/A
Recruiting NCT04909593 - Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial N/A
Withdrawn NCT05347108 - Real-Time Accurate Pathology Inspection and Decompression Study
Recruiting NCT03880500 - Spinal Segment MRI Perfusion and Diffusion Response to Spinal Manipulation in Low Back Pain Patients N/A
Withdrawn NCT03110523 - A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis of the Lumbar Spine Phase 3
Recruiting NCT05626049 - Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP) Phase 4
Recruiting NCT05261581 - Evaluation of Erector Spina Plane Block(ESPB)'s Effectiveness on Patients With Lumbar Radiculopathy Early Phase 1
Not yet recruiting NCT04407884 - Long Term Use of a High Energy Pulsed Heating Device in the Management of Chronic Pain N/A
Enrolling by invitation NCT04312685 - Transitioning to a Valve -Gated Intrathecal Drug Delivery System N/A
Completed NCT04503109 - Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System N/A
Completed NCT04156009 - Lavender Aromatherapy Spine Procedure Study N/A